IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ICCM IceCure Medical Ltd.

Market Closed 05-31 16:00:00 EDT

1.07

+0.01

+0.94%

盘后1.06

-0.01-0.93%

19:59 EDT

High1.11	Low1.06	Vol37.63K
Open1.10	D1 Closing1.06	Amplitude4.72%
Mkt Cap48.93M	Tradable Cap20.23M	Total Shares45.73M
T/O40.68K	T/O Rate0.20%	Tradable Shares18.90M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ICCM","market":"US","secType":"STK","nameCN":"IceCure Medical Ltd.","latestPrice":1.07,"timestamp":1717185600000,"preClose":1.06,"halted":0,"volume":37633,"hourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.07,"latestTime":"19:59 EDT","volume":1035,"amount":1097.1,"timestamp":1717199958124},"delay":0,"floatShares":18903444,"shares":45729684,"eps":-0.321041,"marketStatus":"Market Closed","change":0.01,"latestTime":"05-31 16:00:00 EDT","open":1.1,"high":1.11,"low":1.06,"amount":40684.208374,"amplitude":0.04717,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.321041,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1717401600000},"marketStatusCode":7,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":1.06,"preHourTrading":{"tag":"盘前","latestPrice":1.06,"preClose":1.06,"latestTime":"08:49 EDT","volume":200,"amount":212,"timestamp":1717159758353},"postHourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.07,"latestTime":"19:59 EDT","volume":1035,"amount":1097.1,"timestamp":1717199958124},"volumeRatio":0.40861730425958787},"requestUrl":"/m/hq/s/ICCM","defaultTab":"news","newsList":[{"id":"2439163209","title":"IceCure Medical First Quarter 2024 Earnings: Revenues Disappoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2439163209","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2439163209?lang=en_us&edition=fundamental","pubTime":"2024-05-31 20:17","pubTimestamp":1717157843,"startTime":"0","endTime":"0","summary":"IceCure Medical ( NASDAQ:ICCM ) First Quarter 2024 Results Key Financial Results Revenue: US$743.0k (up 4.6% from 1Q...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-iccm/icecure-medical/news/icecure-medical-first-quarter-2024-earnings-revenues-disappo","is_publish_highlight":false,"gpt_icon":0},{"id":"2439460685","title":"Icecure Medical: Strong Sales Growth and Promising Regulatory Prospects Underpin Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2439460685","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2439460685?lang=en_us&edition=fundamental","pubTime":"2024-05-29 18:17","pubTimestamp":1716977828,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Icecure Medical (ICCM – Research Report) today and set a price target of $3.00. Yi Chen ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/icecure-medical-strong-sales-growth-and-promising-regulatory-prospects-underpin-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/icecure-medical-strong-sales-growth-and-promising-regulatory-prospects-underpin-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2438305227","title":"IceCure Medical Sees Strong Q1 Growth, Awaits FDA Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2438305227","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2438305227?lang=en_us&edition=fundamental","pubTime":"2024-05-28 22:45","pubTimestamp":1716907521,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical reports a robust first quarter in 2024, with a 30% surge in sales of their ProSense®...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-sees-strong-q1-growth-awaits-fda-nod?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-sees-strong-q1-growth-awaits-fda-nod?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2438376733","title":"Icecure Medical Q1 EPS $(0.08), Inline, Sales $743.00K Miss $875.50K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2438376733","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2438376733?lang=en_us&edition=fundamental","pubTime":"2024-05-28 20:45","pubTimestamp":1716900333,"startTime":"0","endTime":"0","summary":"Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is unchanged from the same period last year.  The company reported quarterly sales of $743.00","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/39037705/icecure-medical-q1-eps-0-08-inline-sales-743-00k-miss-875-50k-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2438375768","title":"Press Release: IceCure Medical Maintains Positive Momentum and Reports Sales Growth for Cryoablation System in First Quarter of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2438375768","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2438375768?lang=en_us&edition=fundamental","pubTime":"2024-05-28 20:30","pubTimestamp":1716899400,"startTime":"0","endTime":"0","summary":"IceCure Medical Maintains Positive Momentum and Reports Sales Growth for Cryoablation System in First Quarter of 2024. -- 30% sales growth reflects continued adoption of ProSense in the U.S.-- Major milestones achieved: - Completion of landmark ICE3 trial for breast. demonstrate ProSense's efficacy and safety across numerous indications. Reported and Submitted Full ICE3 Breast Cancer Study Data to FDA: IceCure completed the largest controlled multicenter clinical trial ever performed for liquid nitrogen  based cryoablation of early-stage malignant breast tumors. Per the analysis, at the 5-year follow-up evaluation, 96.3% of the subgroup of patients treated with ProSense cryoablation, followed by hormone therapy, were estimated to be free from local recurrence. 100% patient and physician satisfaction was reported. IceCure submitted the final ICE3 data, along with other analyses and data, to the FDA requesting marketing authorizati","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2438126325","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2438126325","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2438126325?lang=en_us&edition=fundamental","pubTime":"2024-05-28 18:00","pubTimestamp":1716890400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Bank of Nova Scotia                              2Q      1.14   6:00 AM. Box Inc. Class A                                 1Q       .36   4:05 PM. Okta Inc. Class A                               1Q       .54   4:01 PM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2437410735","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2437410735","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2437410735?lang=en_us&edition=fundamental","pubTime":"2024-05-23 18:00","pubTimestamp":1716458400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":1},{"id":"2437233475","title":"IceCure Medical Shareholders Approve All Agendas","url":"https://stock-news.laohu8.com/highlight/detail?id=2437233475","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2437233475?lang=en_us&edition=fundamental","pubTime":"2024-05-22 04:58","pubTimestamp":1716325080,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical Ltd. successfully held its Annual and Special General Meeting of Shareholders in May...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-shareholders-approve-all-agendas?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-shareholders-approve-all-agendas?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2437431417","title":"IceCure Medical to Report First Quarter 2024 Financial & Operational Results on May 28, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2437431417","media":"PR Newswire","top":-1,"share":"https://ttm.financial/m/news/2437431417?lang=en_us&edition=fundamental","pubTime":"2024-05-21 20:30","pubTimestamp":1716294600,"startTime":"0","endTime":"0","summary":"CAESAREA, Israel, May 21, 2024 /PRNewswire/ --IceCure Medical Ltd.  , developer of the ProSense System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, announced today that it will issue a press release containing its financial and operational results as of and for the three months ended March 31, 2024 before the Nasdaq Stock Market opens on Tuesday, May 28, 2024. The Company will discuss such results and other corporate developments on a conference call at 11:00 a.m. EDT that day.IceCure Medical  develops and markets ProSense, an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors  by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide for the indicati","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YnQX7wEK2LTeiBFVJSWsDA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/9e5e9d6bc6d50c04d9d0833c89b78be3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YnQX7wEK2LTeiBFVJSWsDA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/9e5e9d6bc6d50c04d9d0833c89b78be3"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/icecure-medical-report-first-quarter-123000934.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icecure-medical-report-first-quarter-123000934.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435592277","title":"Here's Why It's Unlikely That IceCure Medical Ltd's (NASDAQ:ICCM) CEO Will See A Pay Rise This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2435592277","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2435592277?lang=en_us&edition=fundamental","pubTime":"2024-05-14 19:06","pubTimestamp":1715684796,"startTime":"0","endTime":"0","summary":"IceCure Medical to hold its Annual General Meeting on 20th of May. CEO Eyal Shamir's total compensation includes salary of US$416.4k. The total compensation is similar to the average for the industry. Over the past three years, IceCure Medical's EPS fell by 14%  and over the past three years, the total loss to shareholders 29%. The results at IceCure Medical Ltd  have been quite disappointing recently and CEO Eyal Shamir bears some responsibility for this. Shareholders will be interested in what the board will have to say about turning performance around at the next AGM on 20th of May. It would also be an opportunity for shareholders to influence management through voting on company resolutions such as executive remuneration, which could impact the firm significantly. The data we present below explains why we think CEO compensation is not consistent with recent performance.Comparing IceCure Medical Ltd's CEO Compensation With The Industry. Has IceCure Medical Ltd Been A Good Investment","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-unlikely-icecure-medical-110636687.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433783619","title":"IceCure’s ProSense Shows Promise in Japanese Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2433783619","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2433783619?lang=en_us&edition=fundamental","pubTime":"2024-05-07 21:59","pubTimestamp":1715090355,"startTime":"0","endTime":"0","summary":"Icecure Medical Ltd. (ICCM) has released an update. IceCure Medical Ltd. reports successful results from a Japanese study indicating no local breas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecures-prosense-shows-promise-in-japanese-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecures-prosense-shows-promise-in-japanese-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2428514056","title":"IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2428514056","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2428514056?lang=en_us&edition=fundamental","pubTime":"2024-04-18 23:07","pubTimestamp":1713452820,"startTime":"0","endTime":"0","summary":"IceCure Medical ICCM recently announced that the company had submitted final data to the FDA requesting market authorization for its ProSense System.ProSense is designed to provide cryoablation, an outpatient technique that treats breast cancer in 20–40 minutes. It requests FDA approval to use cryoablation and adjuvant hormone therapy in the treatment of individuals with early-stage T1 invasive breast cancer.In the past six months, ICCM shares have gained 41.8% compared with the industry’s rise of 9.7%. The S&P 500 has gained 17.3% in the same time frame.The clinical trial for cryoablation of low-risk, early-stage malignant breast cancers using liquid nitrogen was carried out as part of the ICE3 research. This innovative study evaluated IceCure's minimally invasive 20-to-40-minute outpatient cryoablation procedure; the five-year recurrence-free rates were in line with expectations and showed similar outcomes to lumpectomy, the current standard of care for patients with early-stage brea","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icecure-medical-iccm-submits-final-150700026.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428312766","title":"BTTR, ICCM and SXTC among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2428312766","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428312766?lang=en_us&edition=fundamental","pubTime":"2024-04-17 20:21","pubTimestamp":1713356479,"startTime":"0","endTime":"0","summary":"Losers: Arrowroot Acquisition Corp  -34%. Hub Cyber Security Ltd  -22%. Longeveron  -18% announces exercise of warrants for $6.2 Million gross proceeds. Sage Therapeutics  -19% after mid-stage setback for Parkinson’s disease candidate. Connexa Sports Technologies  -19%. China SXT Pharmaceuticals  -16%.  Iczoom Group  -14%. First Wave BioPharma  -9% as CEO James Sapirstein to present at the planet MicroCap showcase. Indonesia Energy Corp Ltd  -9%. Auddia  -7%. J.B. Hunt Transport Services  -7% after Q1 earnings release. Autodesk  -7% to delay annual report due to internal investigation. Better Choice Company  -6%. Inspire Medical Systems  -6%. Icecure Medical Ltd  -6%. Resmed  -5%. ASML Holding NV  -5% after Q1 earnings release. Urban Outfitters  -5%.   More on pre-market losers & stocks.  IceCure Medical Ltd.  Q4 2023 Earnings Call Transcript FDA agrees to review IceCure request for De Novo classification Financial information for Better Choice Company Seeking Alpha’s Quant Rating on I","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4090404-bttr-iccm-and-sxtc-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2427854787","title":"IceCure Medical Eyes FDA Approval with Promising Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2427854787","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2427854787?lang=en_us&edition=fundamental","pubTime":"2024-04-16 08:58","pubTimestamp":1713229095,"startTime":"0","endTime":"0","summary":"Icecure Medical Ltd. (ICCM) has released an update. IceCure Medical Ltd. has announced the submission of final trial results to the FDA, showing a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-eyes-fda-approval-with-promising-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-eyes-fda-approval-with-promising-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.icecure-medical.com","stockEarnings":[{"period":"1week","weight":0.0388},{"period":"1month","weight":-0.0855},{"period":"3month","weight":-0.1575},{"period":"6month","weight":0.0388},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.1487},{"period":"1year","weight":0.2502},{"period":"ytd","weight":0.1095}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.","exchange":"NASDAQ","name":"IceCure Medical Ltd.","nameEN":"IceCure Medical Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest IceCure Medical Ltd.(ICCM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"IceCure Medical Ltd.,ICCM,IceCure Medical Ltd.股票,IceCure Medical Ltd.股票老虎,IceCure Medical Ltd.股票老虎国际,IceCure Medical Ltd.行情,IceCure Medical Ltd.股票行情,IceCure Medical Ltd.股价,IceCure Medical Ltd.股市,IceCure Medical Ltd.股票价格,IceCure Medical Ltd.股票交易,IceCure Medical Ltd.股票购买,IceCure Medical Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest IceCure Medical Ltd.(ICCM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}